Today: 26 January 2026
Subscribe
Browse Category

ASX:NEC News 26 January 2026

Australian dollar jumps to a 15-month high as rate-hike bets return

Australian dollar jumps to a 15-month high as rate-hike bets return

SYDNEY, Jan 26, 2026, 20:22 AEDT The Australian dollar surged to its strongest level since September 2024 on Monday, trading close to $0.6917. This spike followed a broad sell-off in the U.S. dollar, triggered by a sharp rebound in Japan’s yen. Thin liquidity, thanks to holidays in Australia and New Zealand, pushed volatility higher throughout the session. (Reuters) The shift…
26 January 2026
···

Stock Market Today

  • Sarepta Therapeutics Faces Biotech Headwinds Amid Potential Upside
    January 26, 2026, 8:22 AM EST. Sarepta Therapeutics (NASDAQ: SRPT) operates in rare disease biotech, focusing on Duchenne muscular dystrophy treatments with drugs like EXONDYS 51. Its stock trades near $21.13, after a wide 52-week range of $11.93 to $119.02, reflecting sector volatility. Despite a 14.5% revenue decline and negative earnings per share (-2.83), the forward price-to-earnings ratio of 6.77 indicates some expected profitability. Analyst ratings are mixed; 7 buy, 14 hold, and 5 sell, with an average target price slightly below current levels. Technical indicators show the stock close to oversold levels, suggesting a possible entry point for investors. Sarepta's future hinges on its drug pipeline and strategic partnerships as it navigates financial pressures common in biotech firms investing heavily in research and development.
Go toTop